KR910004208A - 안정성인자 viii의 제조방법 - Google Patents
안정성인자 viii의 제조방법 Download PDFInfo
- Publication number
- KR910004208A KR910004208A KR1019900011997A KR900011997A KR910004208A KR 910004208 A KR910004208 A KR 910004208A KR 1019900011997 A KR1019900011997 A KR 1019900011997A KR 900011997 A KR900011997 A KR 900011997A KR 910004208 A KR910004208 A KR 910004208A
- Authority
- KR
- South Korea
- Prior art keywords
- treatment
- factor vii
- carried out
- adsorbents
- solution
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
내용 없음.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (10)
- 아미도용해 활성/단백질가수분해 활성이 있고 인자 Ⅷ을 분해하는 효소 및 전구효소와 결합하는 흡착제로 처리 한후 안정하고, 경우에 따라, 저온살균 처리한 인자 Ⅷ을 공지된 방법에 따라 우수한 수율로 수득할 수 있음을 특징으로하는, F Ⅷ의 제조에 통상적으로 사용되는 것들과 같은 인자 Ⅷ-함유 혈장 분획, 바람직하게는 용해된 저온침전물 또는 콘(Cohn) 분획 Ⅰ의 처리방법.
- 인자 Ⅷ-함유 용액으로부터 공지된 방법에 따라 인자 Ⅷ을 수득하기전에 이용액을 Al(OH)3, 음이온 교환기 또는Ca3(PO4)2상에서 2회 이상에 걸쳐 미리 흡착처리함을 특징으로하여, 특이활성 및 안정성이 높은 인자 Ⅷ을 제조하는 방법.
- 제2항에 있어서, 흡착과정을 다양한 흡착제상에서 수행하는 방법.
- 제2항에 있어서, 처리과정을 친수성 매트릭스 및 음이온 그룹을 지닌 염기성 이온 교환기로 수행하는 방법.
- 제2항에 있어서, 처리과정을 폴리삭카라이드 및 음이온 그룹을 기본으로하는 매트릭스를 지닌 염기성 음이온 교환기로 수행하는 방법.
- 제2항에 있어서, 처리과정을 pH 6.5 내지 7.5 및 전도율 10 내지 15㎳에서 수행하는 방법.
- 제2항에 있어서, 처리과정을 어떠한 시트레이트 이온 또는 2가 금속 이온에 대한 기타의 트랩도 함유하지 않는 매질중에서 수행하는 방법.
- 제2항에 있어서, 2종의 상이한 흡착체를 순서대로 가한다음 상등액을 분리해내는 방법.
- 제2항에 있어서, 저온살균과정을 추가로 수행하는 방법.
- 제2항에 있어서, 흡착제를 용액의 약 20 내지 30g/ℓ의 양으로 사용하는 방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEP39260348 | 1989-08-07 | ||
DEP3926034.8 | 1989-08-07 | ||
DE3926034A DE3926034C3 (de) | 1989-08-07 | 1989-08-07 | Verfahren zur Herstellung eines stabilen Faktors VIII |
Publications (2)
Publication Number | Publication Date |
---|---|
KR910004208A true KR910004208A (ko) | 1991-03-28 |
KR0174262B1 KR0174262B1 (ko) | 1999-02-18 |
Family
ID=6386638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019900011997A KR0174262B1 (ko) | 1989-08-07 | 1990-08-06 | 안정성 인자 viii의 제조 방법 |
Country Status (12)
Country | Link |
---|---|
US (1) | US5424401A (ko) |
EP (1) | EP0412466B1 (ko) |
JP (1) | JP3180957B2 (ko) |
KR (1) | KR0174262B1 (ko) |
AT (1) | ATE101041T1 (ko) |
AU (1) | AU635298B2 (ko) |
CA (1) | CA2022650C (ko) |
DE (2) | DE3926034C3 (ko) |
DK (1) | DK0412466T3 (ko) |
ES (1) | ES2062222T3 (ko) |
IE (1) | IE63919B1 (ko) |
PT (1) | PT94917B (ko) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4111393A1 (de) * | 1991-04-09 | 1992-10-15 | Behringwerke Ag | Stabilisierte faktor viii-praeparationen |
SE9403915D0 (sv) * | 1994-11-14 | 1994-11-14 | Annelie Almstedt | Process A |
US5659017A (en) * | 1995-11-07 | 1997-08-19 | Alpha Therapeutic Corporation | Anion exchange process for the purification of Factor VIII |
US6057164A (en) * | 1996-03-08 | 2000-05-02 | Octapharma Ag | Process for testing suitability of protein fractions containing factor VIII |
DE60035260T2 (de) | 1999-02-22 | 2007-10-18 | The University Of Connecticut, Farmington | Neue albuminfreie faktor viii formulierungen |
NZ593190A (en) | 2008-11-07 | 2013-01-25 | Baxter Int | Factor viii formulations |
WO2015107222A1 (en) * | 2014-01-20 | 2015-07-23 | Octapharma Ag | A process for manufacturing factor viii having an improved ratio of fviii:c/fviii:ag |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE713764A (ko) * | 1967-05-01 | 1968-09-16 | Baxter Travenol Lab | |
JPS52125609A (en) * | 1976-04-09 | 1977-10-21 | Green Cross Corp:The | Purification of agglutination factor viii |
CA1054052A (en) * | 1976-08-14 | 1979-05-08 | Edward Shanbrom | Simplified method for preparation of high yield, high purity factor viii concentrate |
DE2902158A1 (de) * | 1979-01-20 | 1980-07-31 | Biotest Serum Institut Gmbh | Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen |
US4305870A (en) * | 1979-01-31 | 1981-12-15 | Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte | Intravenous plasma derivatives and their production |
DE2916711A1 (de) * | 1979-04-25 | 1980-11-06 | Behringwerke Ag | Blutgerinnungsfaktoren und verfahren zu ihrer herstellung |
SE448945B (sv) * | 1979-12-20 | 1987-03-30 | Blombaeck E G B | Forfarande for rening och /eller koncentrering av faktor viii-komplexet |
US4361509A (en) * | 1981-12-14 | 1982-11-30 | Scripps Clinic And Research Foundation | Ultrapurification of factor VIII using monoclonal antibodies |
US4495175A (en) * | 1982-08-05 | 1985-01-22 | University Of Rochester | Preparation of highly purified human antihemophilic factor |
DE3432083A1 (de) * | 1984-08-31 | 1986-03-06 | Behringwerke Ag, 3550 Marburg | Pasteurisierte, isoagglutininfreie faktor viii-praeparation und verfahren zu ihrer herstellung |
US4743680A (en) * | 1985-02-01 | 1988-05-10 | New York University | Method for purifying antihemophilic factor |
CA1293941C (en) * | 1985-11-08 | 1992-01-07 | Maria Erlinda Co-Sarno | Method for preparing antihemophilic factor (ahf) by cold precipitation and for improving solubility of recovered ahf product |
JPS63108000A (ja) * | 1986-05-15 | 1988-05-12 | Green Cross Corp:The | 第8因子の精製方法 |
FR2632309B1 (fr) * | 1988-06-07 | 1990-08-24 | Lille Transfusion Sanguine | Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus |
FR2681867B1 (fr) * | 1991-09-26 | 1993-12-31 | Pasteur Merieux Serums Vaccins | Procede de purification du facteur viii et preparations obtenues. |
-
1989
- 1989-08-07 DE DE3926034A patent/DE3926034C3/de not_active Expired - Fee Related
-
1990
- 1990-08-03 CA CA002022650A patent/CA2022650C/en not_active Expired - Lifetime
- 1990-08-03 IE IE281790A patent/IE63919B1/en not_active IP Right Cessation
- 1990-08-04 ES ES90115005T patent/ES2062222T3/es not_active Expired - Lifetime
- 1990-08-04 DK DK90115005.2T patent/DK0412466T3/da active
- 1990-08-04 AT AT90115005T patent/ATE101041T1/de not_active IP Right Cessation
- 1990-08-04 DE DE90115005T patent/DE59004488D1/de not_active Expired - Lifetime
- 1990-08-04 EP EP90115005A patent/EP0412466B1/de not_active Expired - Lifetime
- 1990-08-06 AU AU60150/90A patent/AU635298B2/en not_active Expired
- 1990-08-06 JP JP20694790A patent/JP3180957B2/ja not_active Expired - Lifetime
- 1990-08-06 PT PT94917A patent/PT94917B/pt not_active IP Right Cessation
- 1990-08-06 KR KR1019900011997A patent/KR0174262B1/ko not_active IP Right Cessation
-
1993
- 1993-12-14 US US08/166,156 patent/US5424401A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DK0412466T3 (da) | 1994-05-24 |
DE3926034C3 (de) | 1996-11-21 |
AU6015090A (en) | 1991-02-07 |
IE902817A1 (en) | 1991-02-27 |
EP0412466A2 (de) | 1991-02-13 |
PT94917A (pt) | 1991-04-18 |
PT94917B (pt) | 1997-05-28 |
DE3926034C2 (ko) | 1992-06-04 |
CA2022650A1 (en) | 1991-02-08 |
JPH03148294A (ja) | 1991-06-25 |
EP0412466B1 (de) | 1994-02-02 |
DE3926034A1 (de) | 1991-02-14 |
IE63919B1 (en) | 1995-06-14 |
ATE101041T1 (de) | 1994-02-15 |
ES2062222T3 (es) | 1994-12-16 |
EP0412466A3 (en) | 1991-09-18 |
AU635298B2 (en) | 1993-03-18 |
JP3180957B2 (ja) | 2001-07-03 |
CA2022650C (en) | 2001-06-05 |
US5424401A (en) | 1995-06-13 |
KR0174262B1 (ko) | 1999-02-18 |
DE59004488D1 (de) | 1994-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3060075D1 (en) | Process for the preparation of fibrinogene, a prothrombine complex containing the coagulation factors ii, vii, ix, and x, antithrombine iii, and a solution containing storable serum proteins | |
ATE179425T1 (de) | Verfahren zur abreicherung oder entfernung von endotoxinen | |
US5409990A (en) | Complex containing coagulation factor IX | |
KR910004208A (ko) | 안정성인자 viii의 제조방법 | |
US5071961A (en) | Method of enrichment of coagulation factors ii, vii, ix and x | |
EP0023860A3 (en) | Improved method for preparing plasminogen activator, activator thus obtained and medicine comprising it | |
AU658238B2 (en) | A process for the production of a virus-free concentrate of thrombin | |
CN1105779C (zh) | 一种从生物原料中制备因子ix的方法 | |
US4027012A (en) | Process for the extraction of components having anticoagulant activity "in vivo" from snake venoms and products obtained | |
US3509070A (en) | Adsorbent for chromatographic purification of virus | |
Fukutaka et al. | Direct evidence for cooperation of the 17‐and 23‐kDa proteins in the recovery of oxygen evolution in cholate‐treated thylakoids | |
EP0518448B1 (en) | A method for isolating proteins from milk and a method for processing milk | |
KR920700220A (ko) | 활성 단백질c의 제조방법과 이러한 방법으로 제조된 활성 단백질c | |
ES372113A1 (es) | Procedimiento de preparacion de un complejo de protrombina. | |
GB906860A (en) | Improvements relating to blood coagulation test reagents | |
DE2309280A1 (de) | Verfahren zur herstellung von reiner alpha-amylase durch affinitaetschromatographie | |
KR820002452A (ko) | 항생물질 네오스라마이신(neothramycin)의 정제방법 | |
CH646684A5 (de) | Verfahren zur entfernung des phenylalanins aus eiweisshydrolysaten oder fleischaromakonzentraten. | |
GB616278A (en) | A process for the removal of impurities of an organic nature from aqueous solutions of sugars | |
KR830007140A (ko) | 이온 교환수지용 에멀젼 재생제 | |
KR790001535B1 (ko) | 유로키나제의 추출방법 | |
JPS57100915A (en) | Purification of aqueous solution of alkali chloride | |
KR900004933A (ko) | 조직 플라스미노겐 액티베이터의 정제방법 | |
KR910009289A (ko) | 가습기용 살균제의 제조방법 | |
JPS5265788A (en) | Adsorbent for artificial kidney |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
N231 | Notification of change of applicant | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121019 Year of fee payment: 15 |
|
EXPY | Expiration of term |